Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations

SAN FRANCISCO: SAN FRANCISCO, Jan. 11, 2022 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Persephone Biosciences, a privately held company investigating the human microbial ecosystem's effect on therapeutic treatment, today announced a collaboration for the long-term clinical study of patients with colorectal cancer (CRC)...

Click to view original post